risk

  1. Chandelier

    Reproducible smoker’s paradox in COVID-19 - comparative evidence from Swedish and Norwegian cohorts, 2026, Kirui et al.

    Reproducible smoker’s paradox in COVID-19 - comparative evidence from Swedish and Norwegian cohorts Abstract Literature on the impact of smoking on COVID-19 has been inconsistent, and the association remains incompletely understood. To assess the effect of smoking on COVID-19 outcomes using...
  2. Chandelier

    Elevated risk of first-time pulmonary hypertension among COVID-19 survivors: a 4.5-year longitudinal study, 2026, Changela et al.

    Elevated risk of first-time pulmonary hypertension among COVID-19 survivors: a 4.5-year longitudinal study Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection could result in pulmonary vascular injury, systemic inflammation, and endothelial dysfunction...
  3. Sean

    High risk of autoimmune diseases after COVID-19, 2023, Sharma & Bayry

    High risk of autoimmune diseases after COVID-19 Chetan Sharma & Jagadeesh Bayry Nature Reviews Rheumatology (2023) - Full Text ABSTRACT: The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking despite numerous case reports and small series. Two studies that use...
Back
Top Bottom